Starcoin Group Limited (399) Requests Review of Listing Committee Decision on Rule 13.24

Bulletin Express

Feb 10

Starcoin Group Limited (formerly known as Innovative Pharmaceutical Biotech Limited), Stock Code 399, announced that the Stock Exchange of Hong Kong has determined the company did not maintain a sufficient level of operations as required under Rule 13.24 of the Listing Rules. Previous announcements dated 17 November 2025, 24 November 2025, and 2 February 2026 disclosed the decision by the Stock Exchange and the subsequent review application filed with the Listing Committee.

According to the latest disclosure, after the Listing Committee’s verdict (the “LC Decision”), a written request was submitted on 10 February 2026 to refer the matter to the Listing Review Committee. The outcome of this review remains uncertain.

Relevant stakeholders are advised to stay alert to further developments and exercise caution when dealing in the company’s securities. The board also stated it will make additional announcements if necessary under the Listing Rules.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1166255992"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1166255992\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1166255992?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-10 23:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1166255992","market":"us","top_or_hot":-1,"title":"Starcoin Group Limited (399) Requests Review of Listing Committee Decision on Rule 13.24","media":"Bulletin Express","content":"<p>Starcoin Group Limited (formerly known as Innovative Pharmaceutical Biotech Limited), Stock Code 399, announced that the Stock Exchange of Hong Kong has determined the company did not maintain a sufficient level of operations as required under Rule 13.24 of the Listing Rules. Previous announcements dated 17 November 2025, 24 November 2025, and 2 February 2026 disclosed the decision by the Stock Exchange and the subsequent review application filed with the Listing Committee.</p>\n<p>According to the latest disclosure, after the Listing Committee’s verdict (the “LC Decision”), a written request was submitted on 10 February 2026 to refer the matter to the Listing Review Committee. The outcome of this review remains uncertain.</p>\n<p>Relevant stakeholders are advised to stay alert to further developments and exercise caution when dealing in the company’s securities. The board also stated it will make additional announcements if necessary under the Listing Rules.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Starcoin Group Limited (399) Requests Review of Listing Committee Decision on Rule 13.24</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStarcoin Group Limited (399) Requests Review of Listing Committee Decision on Rule 13.24\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-02-10 23:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Starcoin Group Limited (formerly known as Innovative Pharmaceutical Biotech Limited), Stock Code 399, announced that the Stock Exchange of Hong Kong has determined the company did not maintain a sufficient level of operations as required under Rule 13.24 of the Listing Rules. Previous announcements dated 17 November 2025, 24 November 2025, and 2 February 2026 disclosed the decision by the Stock Exchange and the subsequent review application filed with the Listing Committee.</p>\n<p>According to the latest disclosure, after the Listing Committee’s verdict (the “LC Decision”), a written request was submitted on 10 February 2026 to refer the matter to the Listing Review Committee. The outcome of this review remains uncertain.</p>\n<p>Relevant stakeholders are advised to stay alert to further developments and exercise caution when dealing in the company’s securities. The board also stated it will make additional announcements if necessary under the Listing Rules.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00399","symbol_name":"星太链集团","start_time":0,"source_url":"","article_id":"1166255992","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1166255992","pubTimestamp":1770738163,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Starcoin Group Limited (formerly known as Innovative Pharmaceutical Biotech Limited), Stock Code 399, announced that the Stock Exchange of Hong Kong has determined the company did not maintain a...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00399":"星太链集团"},"translate_title":"星币集团有限公司(399)要求覆核上市委员会根据第13.24条作出的决定","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00399":1},"content_text":"Starcoin Group Limited (formerly known as Innovative Pharmaceutical Biotech Limited), Stock Code 399, announced that the Stock Exchange of Hong Kong has determined the company did not maintain a sufficient level of operations as required under Rule 13.24 of the Listing Rules. Previous announcements dated 17 November 2025, 24 November 2025, and 2 February 2026 disclosed the decision by the Stock Exchange and the subsequent review application filed with the Listing Committee.\nAccording to the latest disclosure, after the Listing Committee’s verdict (the “LC Decision”), a written request was submitted on 10 February 2026 to refer the matter to the Listing Review Committee. The outcome of this review remains uncertain.\nRelevant stakeholders are advised to stay alert to further developments and exercise caution when dealing in the company’s securities. The board also stated it will make additional announcements if necessary under the Listing Rules.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}